Mirzyme Therapeutics Limited (10133310) is a private limited with share capital incorporated on 19/04/2016 (10 years old) and registered in birmingham, B74BB. The company operates under SIC code 72110 and is classified as Micro.
Mirzyme therapeutics is an innovative biopharmaceutical company that focuses on the development and commercialisation of diagnostics and drugs for women with pregnancy complications, specifically preeclampsia
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:04-05-2023
Second Filing Capital Allotment Shares
Category:Capital
Date:04-05-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:26-09-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:19-05-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:28-09-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:14-08-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:02-05-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:21-12-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-07-2020
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-09-2019
Confirmation Statement
Category:Confirmation Statement
Date:28-06-2019
Capital Allotment Shares
Category:Capital
Date:27-06-2019
Capital Allotment Shares
Category:Capital
Date:27-06-2019
Capital Allotment Shares
Category:Capital
Date:27-06-2019
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:30-04-2019
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:23-01-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:14-11-2018
Resolution
Category:Resolution
Date:10-10-2018
Capital Allotment Shares
Category:Capital
Date:02-10-2018
Capital Allotment Shares
Category:Capital
Date:02-10-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:13-09-2018
Confirmation Statement With Updates
Category:Confirmation Statement
Date:22-04-2018
Capital Alter Shares Subdivision
Category:Capital
Date:07-03-2018
Accounts With Accounts Type Dormant
Category:Accounts
Date:18-01-2018
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:23-10-2017
Confirmation Statement With Updates
Category:Confirmation Statement
Date:27-04-2017
Incorporation Company
Category:Incorporation
Date:19-04-2016
Innovate Grants
1
This company received a grant of £443742.19 for Preclinical Development Of The First Orally-Active Substance For The Treatment Of Preeclampsia. The project started on 01/11/2023 and ended on 28/02/2025.